Successful Treatment of Interstitial Pneumonitis Induced by Leflunomide / 대한류마티스학회지
The Journal of the Korean Rheumatism Association
;
: 268-273, 2007.
Artículo
en Coreano
| WPRIM
| ID: wpr-196275
ABSTRACT
Leflunomide is a disease-modifying antirheumatic drug that has been available in Korea since 2003. Leflunomide induced interstitial pneumonitis has been reported as an adverse effect in other countries but not in Korea. A 57-year-old woman was treated with leflunomide since she had been resistant to methotrexate, hydroxychloroquine and sulfasalazine. She developed high fever, dyspnea, and non-productive cough 3 months after the administration of leflunomide. She was diagnosed leflunomide-induced interstitial pneumonitis based on history, physical, laboratory, radiologic and pathologic findings. The patient was treated by prednisolone 1 mg/kg/day with cholestyramine 24 g/day, resulting in dramatic improvement. Here we report a case of leflunomide induced pneumonitis treated successfully with high dose steroid.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neumonía
/
Artritis Reumatoide
/
Sulfasalazina
/
Prednisolona
/
Metotrexato
/
Resina de Colestiramina
/
Enfermedades Pulmonares Intersticiales
/
Tos
/
Disnea
/
Fiebre
Límite:
Femenino
/
Humanos
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
The Journal of the Korean Rheumatism Association
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS